FDA Inspection 1133295 — David S. Siegel, M.D.

David S. Siegel, M.D. — FEI 3009255502

The FDA completed an inspection of David S. Siegel, M.D. on Nov 2, 2020 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 2, 2020
Fiscal Year
2021
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Hackensack, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.